Calithera Biosciences Inc. (CALA)
$0.00
$-0.03
(-99.04%)
As on 05-Jun-2026 09:30EDT
Market cap
$0 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-16 Mln
-
ROE
-1.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.2
-
Debt to Equity
0.1
-
Book Value
$4.2
-
EPS
$-3.9
-
Face value
--
-
Shares outstanding
4,872,497
10 Years Aggregate
CFO
$-416.08 Mln
EBITDA
$-430.89 Mln
Net Profit
$-543.11 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
| -- | -- | -- | -- | -90.6 | -90.8 | -72.2 |
|
BSE Sensex
| -12.3 | -3.9 | -6.2 | -8.3 | 5.9 | 7.3 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
| -86.5 | -14.0 | 42.4 | -51.8 | 156.9 | -57.6 | -62.1 |
|
S&P Small-Cap 600
| 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 | -3.4 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
0.0 | 0.0 | 0.0 | -18.9 | -- | -131.1 | -- | 0.1 |
| 13.8 | 4,386.6 | 3,045.9 | 122.4 | 13.8 | -- | 37.2 | 105.4 | |
| 41.0 | 5,252.7 | 1,105.3 | 133.3 | 15.9 | 32.7 | 38.3 | 12.7 | |
| 232.3 | 12,066.3 | 708.2 | -188.3 | -25.6 | -293.5 | -- | 221.1 | |
| 67.6 | 12,977.8 | 580.0 | -725.9 | -105.2 | -- | -- | 123.7 | |
| 72.6 | 7,459.9 | 769.1 | 47.9 | 5.4 | 7.5 | 198.5 | 11.2 | |
| 23.6 | 11,876.9 | 4,893.0 | -242.0 | -1.5 | -3.7 | -- | 1.8 | |
| 237.0 | 4,648.7 | 274.5 | 153.6 | 76.6 | 15.8 | 30.2 | 4.7 | |
| 61.9 | 5,501.1 | 288.1 | 22.3 | 17.5 | 34.1 | 363.9 | 50.5 | |
| 69.2 | 4,164.1 | 409.5 | -81.3 | -20.1 | -17.5 | -- | 9.1 |
Shareholding Pattern
View DetailsAbout Calithera Biosciences (CALA)
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated... in 2010 and is headquartered in South San Francisco, California. Read more
-
CFO & Secretary
Ms. Stephanie Wong
-
Senior Vice President of Development
Dr. Christopher J. Molineaux Ph.D.
-
Headquarters
South San Francisco, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Calithera Biosciences (CALA)
What is the current share price of Calithera Biosciences Inc (CALA) Today?
The share price of Calithera Biosciences Inc (CALA) is $0.00 (NASDAQ) as of 05-Jun-2026 09:30 EDT. Calithera Biosciences Inc (CALA) has given a return of -90.59% in the last 3 years.
What is the current PB & PE ratio of Calithera Biosciences Inc (CALA)?
Since, TTM earnings of Calithera Biosciences Inc (CALA) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.84
|
0.78
|
|
2021
|
-0.02
|
0.30
|
|
2020
|
-0.20
|
0.17
|
|
2019
|
-0.18
|
0.11
|
|
2018
|
-0.15
|
0.06
|
What is the 52 Week High and Low of Calithera Biosciences Inc (CALA)?
The 52-week high and low of Calithera Biosciences Inc (CALA) are Rs 0.00 and Rs 0.00 as of 07-Jun-2026.
What is the market cap of Calithera Biosciences Inc (CALA)?
Calithera Biosciences Inc (CALA) has a market capitalisation of $ 0 Mln as on 29-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Calithera Biosciences Inc (CALA)?
Before investing in Calithera Biosciences Inc (CALA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.